DM
Deerfield Management Portfolio holdings
AUM
$7.8B
1-Year Est. Return
76.63%
This Fund
S&P 500
1 Year Est. Return
+76.63%
AUM
$7.8B
AUM Growth
+$1.28B
(+20%)
Holding
184
Top Buys
| 1 | +$85.1M | |
| 2 | +$80.6M | |
| 3 | +$63M | |
| 4 |
Stoke Therapeutics
STOK
|
+$54.8M |
| 5 |
Lantheus
LNTH
|
+$48.2M |
Top Sells
| 1 | +$287M | |
| 2 | +$110M | |
| 3 | +$105M | |
| 4 |
Centene
CNC
|
+$97.3M |
| 5 |
Merck
MRK
|
+$86.4M |
Sector Composition
| 1 | Healthcare | 87.23% |
| 2 | Real Estate | 0.35% |
| 3 | Financials | 0.06% |
| 4 | Consumer Discretionary | 0.04% |
| 5 | Consumer Staples | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Varex Imaging
VREX
$551M
| $1.53M | 0.02% |
131,745
-153,462
|
|
||
102
HealthEquity
HQY
$6.66B
| $1.49M | 0.02% |
16,231
+9,171
|
|
||
103
Abbott
ABT
$198B
| $1.43M | 0.02% |
+11,449
|
|
||
104
Maximus
MMS
$4.03B
| $1.43M | 0.02% |
+16,606
|
|
||
105
Stryker
SYK
$148B
| $1.25M | 0.02% |
3,551
+1,563
|
|
||
106
Alphatec Holdings
ATEC
$2B
| $1.21M | 0.02% |
57,277
-7,985
|
|
||
107
STAAR Surgical
STAA
$940M
| $1.2M | 0.02% |
51,894
-45,095
|
|
||
108
Edwards Lifesciences
EW
$50.6B
| $1.17M | 0.02% |
13,702
+7,353
|
|
||
109
UFP Technologies
UFPT
$1.58B
| $1.13M | 0.01% |
5,098
-13,562
|
|
||
110
Kenvue
KVUE
$36.2B
| $1.13M | 0.01% |
65,344
-128,509
|
|
||
111
MiMedx Group
MDXG
$723M
| $1.09M | 0.01% |
160,419
+55,549
|
|
||
112
Integer Holdings
ITGR
$2.97B
| $1.05M | 0.01% |
13,326
+798
|
|
||
113
Revvity
RVTY
$10.7B
| $999K | 0.01% |
10,323
-23,218
|
|
||
114
Azenta
AZTA
$1.19B
| $859K | 0.01% |
25,835
-15,169
|
|
||
115
Arvinas
ARVN
$860M
| $807K | 0.01% |
+68,057
|
|
||
116
Zoetis
ZTS
$54.4B
| $717K | 0.01% |
5,698
-2,856
|
|
||
117
Cooper Companies
COO
$16.4B
| $638K | 0.01% |
7,786
-35,324
|
|
||
118
Schrodinger
SDGR
$895M
| $608K | 0.01% |
+33,987
|
|
||
119
Tandem Diabetes Care
TNDM
$1.71B
| $573K | 0.01% |
26,090
+13,895
|
|
||
120
RxSight
RXST
$313M
| $545K | 0.01% |
+52,257
|
|
||
121
Integra LifeSciences
IART
$812M
| $487K | 0.01% |
39,209
-755,656
|
|
||
122
AbbVie
ABBV
$414B
| $460K | 0.01% |
+2,014
|
|
||
123
Harrow
HROW
$1.98B
| $426K | 0.01% |
+8,693
|
|
||
124
Xeris Biopharma Holdings
XERS
$999M
| $410K | 0.01% |
52,230
-68,670
|
|
||
125
Healthcare Services Group
HCSG
$1.56B
| $406K | 0.01% |
+21,259
|
|